Tolterodine tablets include Tolterodine Tartrate tablets and Tolterodine Fumarate tablets. The initial dose of Tolterodine Tartrate Tablets is 2 mg each time, twice a day. Depending on the patient’s response and tolerance, it may be adjusted downward to 1 mg each time, twice daily. For patients with hepatic insufficiency or who are taking CYP3A4 inhibitors, 1 mg each time, twice daily. The initial dose of tolterodine fumarate tablets is 1.86 mg each time, twice a day. It may be adjusted downward to 0.93 mg each time, twice a day, depending on the patient’s response and tolerance. For those with hepatic insufficiency or taking CYP3A4 inhibitors, 0.93 mg twice a day. Tolterodine Tartrate Tablets and Tolterodine Fumarate Tablets have the same indications, adverse effects and contraindications. Both are indicated for the treatment of symptoms of urinary frequency, urgency or urgency incontinence caused by overstimulation of the bladder. There may be adverse reactions such as dry mouth, dyspepsia, headache, dry eye, dry skin, drowsiness, abnormal sensations, chest pain, allergic reactions, and urinary incontinence. It is contraindicated in people who are allergic to the drug ingredients, in patients with urinary retention, gastric stagnation, uncontrolled narrow-angle glaucoma, in patients with myasthenia gravis, in patients with severe ulcerative colitis, in patients with toxic megacolon, in lactating women, and with caution in pregnant women. If you need to use the above drugs, please consult a professional doctor, follow the doctor’s instructions, rational use of medication.